Giemsa is the optimal counterstain for immunohistochemical detection of BRAF V600E mutation status in pigmented melanomas

Research output: Contribution to journalLetterpeer-review

8 Scopus citations
Original languageEnglish (US)
Pages (from-to)722-724
Number of pages3
JournalJournal of cutaneous pathology
Volume43
Issue number8
DOIs
StatePublished - Aug 1 2016

Keywords

  • BRAF V600E
  • Giemsa
  • immunodetection
  • melanin
  • melanoma

ASJC Scopus subject areas

  • Pathology and Forensic Medicine
  • Histology
  • Dermatology

Cite this